Goldman Sachs Resumes Nuance Communications (NUAN) at Neutral
Get Alerts NUAN Hot Sheet
Price: $55.99 --0%
Rating Summary:
8 Buy, 9 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 17
Rating Summary:
8 Buy, 9 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 17
Join SI Premium – FREE
Goldman Sachs resumes coverage on Nuance Communications (NASDAQ: NUAN) with a Neutral rating and $25 price target.
The firm expects just in-line stock price performance as growth and/or margins are unlikely to from broader voice adoption.
"While we believe voice is approaching a tipping point (given better bandwidth, processing, and data analytics) and see Nuance benefiting from having the largest set of voice and natural language solutions, we don't believe the company's IP represents an insurmountable competitive advantage," the firm said.
Goldman said they could become more positive on the stock in they thought mid-teens growth was sustainable.
For an analyst ratings summary and ratings history on Nuance Communications click here. For more ratings news on Nuance Communications click here.
Shares of Nuance Communications closed at $20.66 yesterday.
The firm expects just in-line stock price performance as growth and/or margins are unlikely to from broader voice adoption.
"While we believe voice is approaching a tipping point (given better bandwidth, processing, and data analytics) and see Nuance benefiting from having the largest set of voice and natural language solutions, we don't believe the company's IP represents an insurmountable competitive advantage," the firm said.
Goldman said they could become more positive on the stock in they thought mid-teens growth was sustainable.
For an analyst ratings summary and ratings history on Nuance Communications click here. For more ratings news on Nuance Communications click here.
Shares of Nuance Communications closed at $20.66 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- Chardan Starts Odysight.AI Inc. (ODYS) at Buy
- Truist Securities Reinstates Pacira Pharmaceuticals (PCRX) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share